| Date | Company | Amount | Investors | Planned use / Other |
|---|---|---|---|---|
| 2009-06-15 | Ipsogen (France) | €2.5 million | See details | |
| 2009-06-15 | Active Biotech (Sweden) | SEK 256 million (€23.6 million) | See details | |
| 2009-06-11 | InnaVirVax (France) | € 1,1 million | CapDecisif Management (France) G1J-Ile de France (France) |
See details |
| 2009-06-05 | Proximagen Neuroscience (UK) | £50 million (before expenses, £49 million net) | See details | |
| 2009-06-01 | ImmunID (France) | €2.4 million | Sofimac Partners (France) Vizille Capital Innovation (France) CEA Investissement (France) |
See details |
| 2009-05-29 | Apeptico (Austria) | € 1.2 million | Austrian Research Promotion Agency (Austria) | See details |
| 2009-05-29 | Apeptico (Austria) | € 1 million | BioScience Ventures Group (Germany) Dr. Jürg Geigy (Swiss business angel) |
See details |
| 2009-05-26 | Cavadis (The Netherlands) | undisclosed | Thuja Capital (The Netherlands) ErasmusMC Biomedical Fund (The Netherlands) UMC Utrecht Holding BV (The Netherlands) Universiteit Utrecht Holding BV (The Netherlands) |
See details |
| 2009-05-26 | Cavadis (The Netherlands) | undisclosed | Thuja Capital (The Netherlands) ErasmusMC Biomedical Fund (The Netherlands) UMC Utrecht Holding BV (The Netherlands) Universiteit Utrecht Holding (The Netherlands) |
See details |
| 2009-05-18 | ReNeuron (UK) | £ 3 million (€ 3.4 million) | See details | |
| 2009-05-12 | NovImmune (Switzerland) | CHF 62.5 million (€41.5 million) | BZ Bank Aktiengesellschaft (Switzerland) | See details |
| 2009-04-28 | TcLand Expression (France) | €1.8 million | OSEO (France) | See details |
| 2009-04-27 | Protaffin (Germany) | €14.1 million ($18.4 million) | Atlas Venture (USA) SR One Limited (the venture capital arm of GSK) Aescap Venture (The Netherlands) Entrepreneurs Fund (The Netherlands) Z-Cube (Italy) |
See details |
| 2009-04-15 | Pharming (The Netherlands) | Up to €20 million | Yorville Advisors Global Master SPV (YA Global - USA) | See details |
| 2009-04-07 | KeyNeurotek Pharmaceuticals (Germany) | € 8.2 million | DVC Deutsche Venture (Germany) IBG Beteiligungsgesellschaft (Germany) KfW (Germany) |
See details |
